Large Scale Genomic Instability as an Additive Prognostic Marker in Early Prostate Cancer
Background: The clinical outcome for the individual prostate cancer patient is often difficult to predict, due to lack of reliable independent prognostic biomarkers. We tested DNA ploidy as a prognostic factor for clinical outcome in 186 patients treated with radical prostatectomy.
Saved in:
Main Authors: | Maria E. Pretorius, Håkon Wæhre, Vera M. Abeler, Ben Davidson, Ljiljana Vlatkovic, Ragnhild A. Lothe, Karl-Erik Giercksky, Håvard E. Danielsen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | Cellular Oncology |
Online Access: | http://dx.doi.org/10.3233/CLO-2009-0463 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Prognostic Value of Adaptive Nuclear Texture Features from Patient Gray Level Entropy Matrices in Early Stage Ovarian Cancer
by: Birgitte Nielsen, et al.
Published: (2012-01-01) -
Somatic Mitochondrial DNA Point Mutations Used as Biomarkers to Demonstrate Genomic Heterogeneity in Primary Prostate Cancer
by: Christian Arstad, et al.
Published: (2020-01-01) -
A Review of Caveats in Statistical Nuclear Image Analysis
by: Helene Schulerud, et al.
Published: (1998-01-01) -
Galectins as New Prognostic Markers and Potential Therapeutic Targets for Advanced Prostate Cancers
by: Diego J. Laderach, et al.
Published: (2013-01-01) -
Synovial sarcoma. Evaluation of Prognosis with Emphasis on the Study of DNA Ploidy and Proliferation (PCNA and Ki-67) Markers
by: José M. Lopes, et al.
Published: (1998-01-01)